| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Werner Kroll | Svp, R&D | 27 May 2022 | |||
| Edward K. Russell | SVP, Business Development | 16 Jan 2022 | |||
| Joseph D. Wilkins Jr. | Director | 27 May 2022 | |||
| RANDALL J. STEWARD | Chief Financial Officer | 03 Feb 2022 | |||
| KENNETH F. BUECHLER | Director | 27 May 2022 | |||
| WIDDER KENNETH J | Director | 27 May 2022 | |||
| Robert J. Bujarski | Chief Operating Officer | 27 May 2022 | |||
| Matthew Strobeck | Director | 27 May 2022 | |||
| MARY LAKE POLAN | Director | 27 May 2022 | |||
| KATHY ORDONEZ | Director | 18 May 2021 | |||
| Tamara A. Ranalli | SVP, Molecular Bus. Unit | 27 May 2022 | |||
| CHARLES P. SLACIK | Director | 25 Jan 2022 | |||
| ANN D. RHOADS | Director | 27 May 2022 | |||
| William J. Ferenczy | SVP, Cardio/Metabolic Unit | 27 May 2022 | |||
| Edward L. Michael | Director | 27 May 2022 | |||
| DOUGLAS C. BRYANT | President & CEO, Director | 27 May 2022 | |||
| Michelle A. Hodges | SVP, General Counsel | 27 May 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|